𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A Systematic Review of RCTs and quasi-RCTs on Traditional Chinese Patent Medicines for Treatment of Chronic Hepatitis B

✍ Scribed by Tao ZHAN; Xing WEI; Ze-qi CHEN; Dong-sheng WANG; Xing-ping DAI

Book ID
114195106
Publisher
Elsevier
Year
2011
Weight
173 KB
Volume
31
Category
Article
ISSN
0254-6272

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Contemporary clinical research of tradit
Contemporary clinical research of traditional Chinese medicines for chronic hepatitis B in China: An analytical review
✍ Lingyi Zhang; Guqi Wang; Weihong Hou; Ping Li; Andrea Dulin; Herbert L. Bonkovsk πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 591 KB

Chronic hepatitis B (CHB) is major global health problem. In China, where about 120,000,000 persons are chronically infected, CHB has been treated for centuries with traditional Chinese medicines (TCMs). This review summarizes and meta-analyzes the results of randomized controlled trials (RCTs) of T

A Systematic Review of Side Effects of N
A Systematic Review of Side Effects of Nucleoside and Nucleotide Drugs Used for Treatment of Chronic Hepatitis B
✍ Vandana Khungar; Steven-Huy Han πŸ“‚ Article πŸ“… 2010 πŸ› Current Science Inc. 🌐 English βš– 217 KB

Although nucleosides and nucleotides have a good safety record for the treatment of hepatitis B, there have been no systematic reviews on this topic. We searched Medline to include studies of the oral antiviral agents for hepatitis B and adverse events, with at least 48 weeks of follow-up from the i